Production Linked Incentive Scheme For Pharmaceuticals

  • IASbaba
  • February 25, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

Production Linked Incentive Scheme For Pharmaceuticals

Part of: GS Prelims and GS- III – Economy; Manufacturing sector

In news

Key takeaways 

  • The Scheme is expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector.
  • It will be part of the umbrella scheme for the Development of the Pharmaceutical Industry.
  • Objective: (1) To enhance India’s manufacturing capabilities by increasing investment; (2) Product diversification to include high-value goods. 
  • Target Groups: The manufacturers who are registered in India will be grouped based on their Global Manufacturing Revenue (GMR) to ensure wider applicability of the scheme
  • Quantum of Incentive: 15,000 crores.
  • Category of Goods covered:
    1. Category 1: Biopharmaceuticals; Complex generic drugs; Patented drugs or drugs nearing patent expiry; Cell-based or gene therapy drugs; Orphan drugs; Other drugs as approved.
    2. Category 2: Active Pharmaceutical Ingredients, Key Starting Materials, Drug Intermediates.
    3. Category 3: Drugs not covered under Category 1 and 2.

Related articles:

Expansion of Production-Linked Incentive Scheme

PLI For Large Scale Electronics Manufacturing

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....